Close
Patheon

News Releases

  • 22 Jul 2015
    Ardian, together with current management, to acquire agrochemicals (ES) and fine chemicals (IM) business activities of DPx Holdings B.V. to gain full independence, expand product portfolio and further international growthArdian, the independent private investment company, today announces the acquisition of the Exclusive Synthesis (ES) and Maleic Anhydride Intermediates & Specialties (IM) business activities, based in Linz, Austria, of DPx Holdings B.V. The parties have agreed not tomore...
  • 22 Jul 2015
    LIVIA Group, a German-based industrial holding, has entered into an agreement to acquire the Capua manufacturing facility and associated employees from Patheon, a leading global provider of outsourced contract development and manufacturing (CDMO) services for the pharma and biopharma industries. Capua, one of the world’s largest independent microbial fermentation-based manufacturing facilities with 1,400m³ fermentor capacity, represents an exceptional investment opportunity for LIVIA in themore...
  • 15 Jul 2015
    Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma industries, has entered into a development contract with Inhibrx, abiologic immunotherapeutic company focused on high, unmet medical needs in oncology, infectious disease and inflammatory conditions.As part of the agreement, Patheon will develop production processes at its Princeton, N.J., facility and will manufacture products at its Brisbane, Australia, location inmore...